Friday, August 22, 2014
Inquirer Daily News

Teething tablets contain deadly nightshade, FDA warns

If you use Hyland's Teething Tablets to try to ease your baby's misery, the U.S. Food and Drug Administration urges you to do this: Throw the stuff away and report any harmful symptoms. The melt-in-the-mouth tablets contain belladonna, also known as deadly nightshade, a plant with a long history of use as a medicine, cosmetic - and poison.

Teething tablets contain deadly nightshade, FDA warns

By Inquirer Staff Writer Marie McCullough:

If you use Hyland's Teething Tablets to try to ease your baby’s misery, the U.S. Food and Drug Administration urges you to do this:

Throw the stuff away and report any harmful symptoms.

The melt-in-the-mouth tablets contain belladonna, also known as deadly nightshade, a plant with a long history of use as a medicine, cosmetic — and poison.

In a consumer alert issued Monday, the FDA said its lab analyses have found that Hyland’s Teething Tablets contain varying amounts of belladonna. FDA has also received reports of children suffering symptoms of belladonna toxicity, including seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating, or agitation.

The manufacturer, Standard Homeopathic Company, agreed to “voluntarily” recall the product from the market after an FDA inspection found the firm’s manufacturing operation was “substandard,” the alert says.

The company advertises the tablets as making teething “easier for mother and baby for years.”

If the tablets have done quite the opposite for you and your baby, the FDA urges you to report side effects to the MedWatch Adverse Event Reporting program: MedWatch or by calling (800) 332-1088.

To check out more Check Up items go to www.philly.com/checkup.

About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Latest Health Videos
Also on Philly.com:
Stay Connected